COVID-19 Research Ramp Down Guidance

COVID-19 Protocol Review Process for Clinical Research Protocol Review Process - Required for Interventional & Non-Interventional Studies We have developed a streamlined process for reviewing COVID-19 protocols that our Mount Sinai investigators are developing as...

COVID-19 Sponsored Research Guidance

GCO Policy for Charging Personal Protective Equipment to NIH Grants and Cooperative Agreements as Direct Costs - Clinical Trials and Clinical Research - NOT-OD-20-164 (09/11/2020) Please see the recently released NIH notice below on charging Personal Protective...

COVID-19 Research Resources & Facilities

Scientific Computing and Data Chest CT scans and chest x-rays now added to COVID-19 datasets Scientific Computing continues to enhance and update the de-identified COVID-19 datasets, which currently consist of over 250 distinct data elements. A radiology file has now...

COVID-19 Laboratory Research Ramp-up Guidance

Dean’s Office Research Update - Guidelines for the new year (01/06/2022) Dear Fellow Researchers, We want to welcome everyone back to campus after the holiday break. As you know, we are in the throes of a surge in COVID-19 cases due to the highly contagious...

COVID-19 Human Subject Research Guidance

Dean’s Office and PPHS Update on On-site Monitoring for Clinical Trials (10/04/2022) TO: All Faculty, Staff, and Students FROM: Rosalind J. Wright, MD MPHDean for Translational Biomedical SciencesIcahn School of Medicine at Mount Sinai Judith A. Aberg, MDDean,...

COVID-19 Protocol Review Process for Clinical Research

A COVID-19 protocol review committee has been established to enhance the research that is being performed at Mount Sinai and ensure that we can provide resources to accommodate as many meritorious studies as possible by minimizing redundancies and competition for finite resources and promoting team science and collaboration.